Carl Magnus Högerkorp
Geen lopende functies
Loopbaan van Carl Magnus Högerkorp
Eerdere bekende functies van Carl Magnus Högerkorp
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Algemeen Directeur | 01-01-2019 | 01-04-2021 |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Algemeen Directeur | 01-05-2017 | 01-10-2018 |
| XINTELA AB | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 | 01-04-2017 |
| Immodulate Pharma AB | Algemeen Directeur | 01-01-2021 | - |
| Oprichter | 01-01-2021 | - | |
| CYXONE AB | Directeur/Bestuurslid | 01-01-2023 | - |
| Algemeen Directeur | 20-06-2022 | - | |
| Operationeel Directeur | 20-05-2021 | 13-12-2022 | |
| Investor Relations Contact | - | - |
Opleiding van Carl Magnus Högerkorp
| University of Lund | Doctorate Degree |
| Lund University School of Economics & Management | Masters Business Admin |
Statistieken
Internationaal
| Zweden | 8 |
Operationeel
| Chief Executive Officer | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| XINTELA AB | Health Technology |
| CYXONE AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Edvince AB
Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
| Immodulate Pharma AB |
